$NSPX 150M A/S @ .0044, unknown cancer biotech stock, cancer treatment patents for it's flagship cancer treatment drug misparigin. SECURES DEAL FOR UP TO $100M IN FINANCING FOR STAGE 3 CLINICAL TRIALS. https://www.otcmarkets.com/stock/NSPX/news/Inspyr-Therapeutics-Secures-a-100-Million-Financing-Agreement-from-Milost-Global?id=153640